Label-free differentiation of human pituitary adenomas by FT-IR spectroscopic imaging

Analytical and Bioanalytical Chemistry

Volumn 403, Issue 3, 2012, Pages 727-735

  Steiner, Gerald ^a,b   Mackenroth, Luisa ^a   Geiger, Kathrin D ^a   Stelling, Allison ^a   Pinzer, Thomas ^a   Uckermann, Ortrud ^a   Sablinskas, Valdas ^b   Schackert, Gabriele ^a   Koch, Edmund ^a   Kirsch, Matthias ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Infrared spectroscopic imaging; Pituitary gland tumors; Supervised classification

Indexed keywords

FOURIER TRANSFORM INFRARED; FT-IR SPECTROSCOPIC IMAGING; HUMAN GROWTH HORMONE; INFRARED SPECTROSCOPIC IMAGING; K-MEANS CLUSTER ANALYSIS; LABEL FREE; LINEAR DISCRIMINANT ANALYSIS; NORMAL TISSUE; ORANGE G; PITUITARY ADENOMA; PITUITARY GLAND; SPECTRAL CLASSIFICATION; SPECTROSCOPIC IMAGING; SUPERVISED CLASSIFICATION; TISSUE TYPES; TUMOR CELLS; TUMOR TISSUES;

AMIDES; BRAIN; CELLS; CLUSTER ANALYSIS; CYTOLOGY; IMAGE CLASSIFICATION;

TUMORS;

HUMAN GROWTH HORMONE;

CHEMISTRY; CLUSTER ANALYSIS; CONFERENCE PAPER; HUMAN; HYPOPHYSIS; HYPOPHYSIS TUMOR; INFRARED SPECTROSCOPY; METHODOLOGY; MULTIVARIATE ANALYSIS; PATHOLOGY;

CLUSTER ANALYSIS; HUMAN GROWTH HORMONE; HUMANS; MULTIVARIATE ANALYSIS; PITUITARY GLAND; PITUITARY NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84861229784     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-5824-y     Document Type: Conference Paper

References (32)

1. Hornyak M, Digre K, Couldwell WT (2009) Neuro-ophthalmologic manifestations of benign anterior skull base lesions. Postgrad Med 121(4):103-114
2. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 15(2):203-216 (Pubitemid 46554515)
3. Vandeva S, Jaffrain-Rea ML, Daly AF, Tichomirowa M, Zacharieva S, Beckers A (2010) The genetics of pituitary adenomas. Best Practice Res Clinical Endocrin Matabol 24(9):461-476
4. Kreutzer J, Fahlbusch R (2004) Diagnosis and treatment of pituitary tumors. Curr Opin Neurol 17(6):693-703 (Pubitemid 39613001)
5. Al-Brahim N Y Y, Asa SL (2006) My approach to pathology of the pituitary gland. J Clin Pathol 59:1245-1253 (Pubitemid 46055199)
6. Saraswathy A, Jayasree RS, Baiju KV, Gupta AK, Pillai V P M (2009) Optimum wavelength for the differentiation of brain tumor tissue using autofluorescence spectroscopy. Photomed Laser Surg 27(3):425-433
7. Everlin LS, Dill AL, Golby AJ, Ligon KL, Wiseman JM, Cooks RG, Agar N Y R (2010) Discrimination of human astrocytoma subtypes by lipid snalysis using desorption electrospray ionization imaging mass spectrometry. Angew Chem Int Ed 49:5993-5956
8. Lee LS, Lin SY, Chi CW, Liu HC, Cheng CL (1995) Nondestructive analysis of the protein conformational structure of human pituitary adenomas using reflectance FT-IR microspectroscopy. Cancer Lett 94:65-69
9. Carmona P, Molina M, Lasagabaster (1994) Structural study of human growth hormone-releasing factor fragment (1-29) by vibrational spectroscopy. Spectrochim Acta 51 A (5): 929-938
10. Steiner G, Küchler S, Hermann A, Koch E, Salzer R, Schackert G, Kirsch M (2008) Rapid and label-free classification of human glioma cells by infrared spectroscopic imaging. Cytometry 73 A: 1158-1164
11. Krafft C, Shapoval L, Sobottka SB, Geiger K, Schackert G, Salzer R (2006) Identification of primary tumors of brain metastases by SIMCA classification of IR spectroscopic images. Biochim Biophys Acta Biomembranes 1758:883-891 (Pubitemid 44223431)
12. Kirsch M, Schackert G, Salzer R, Krafft C (2010) Raman spectroscopic imaging for in vivo detection of cerebral brain metastases. Anal Bioanal Chem 398:1707-1713
13. Mackanos MA, Contag CH (2010) Fiber-optic probes enable cancer detection with FTIR spectroscopy. Trends Biotechnol 28:317-323
14. Stelling A, Salzer R, Kirsch M, Sobottka SB, Geiger K, Koch E, Schackert G, Steiner G (2011) Intra-operative optical diagnostics with vibrational spectroscopy. Anal Bioanal Chem 400:2745-2753
15. Liu Y, Xu Y, Liu Y, Zhang Y, Wang D, Xiu D, Xu Z, Zhou X, Wu J, Ling X (2011) Detection of cervical metastatic lymph nodes in papillary thyroid carcinoma by Fourier transform infrared spectroscopy. Br J Surg 98:380-394
16. Rehman S, Movasaghi Z, Darr JA, Rehman IU (2010) Fourier transform infrared spectroscopic analysis of breast cancer tissues; identifying differences between normal breast, invasive ductal carcinoma, and ductal carcinoma in situ of the breast. Appl Spectr Rev 45:355-368
17. Salzer R, Siesler HW (2009) Infrared and Raman spectroscopic imaging. Wiley-VCH, Weinheim
18. Mordechai S, Sahu RK, Hammody Z, Mark S, Kantarovich K, Guterman H, Podshyvalov A, Goldstein J, Argov S (2004) Possible common biomarkers from FTIR microspectroscopy of cervical cancer and melanoma. J Microscopy 215:86-91 (Pubitemid 38845129)
19. Krafft C, Steiner G, Beleites C, Salzer R (2009) Disease recognition by infrared and Raman spectroscopy. J Biophotonics 2(1-2):13-28
20. Beleites C, Baumgartner R, Bowmann C, Somorjai R, Steiner G, Salzer R, Sowa MG (2005) Variance reduction in estimating classification error using sparse dataset. Chemom Intell Lab Syst 79:91-100 (Pubitemid 41219509)
21. Halmi NS (1978) Immunostaining of growth hormone and prolactin in paraffin-embedded and stored or previously stained materials. J Histochem Cytochem 26(7):486-495 (Pubitemid 8403923)
22. Tibshirani R, Walther G, Hastie T (2001) Estimating the number of clusters in a dataset via the gap statistic. J R Statist Soc B 63:411-423
23. Krafft C, Sobottka SB, Geiger KD, Schackert G, Salzer R (2007) Classification of malignant gliomas by infrared spectroscopic imaging and linear discriminant analysis. Anal Bioanal Chem 387(5):1669-1677
24. Steiner G, Shaw A, Choo-Smith LP, Abuid MH, Schackert G, Sobottka S, Steller W, Salzer R, Mantsch HH (2003) Distinguishing and grading human gliomas by IR spectroscopy. Biopolymers 72(6):464-471 (Pubitemid 37413224)
25. Zhan X, Mesiderio DM (2005) Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives. Mass Spectr Rev 24:783-813 (Pubitemid 41641698)
26. Mulinacci F, Bell S E J, Capella M A H, Gurny R, Arvinte T (2011) Oxidized recombinant human growth hormone that maintains conformational integrity. J Pharm Sci 100(1):110-122
27. Lloyd RV, Jin L, Chandler WF, Horvath E, Stefaneanu L, Kovacs K (1993) Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues. Lab Invest 69(5):570-575 (Pubitemid 24004493)
28. Otsuka F, Tamiya T, Yamauchi T, Ogura T, Ohmoto T, Makino H (1999) Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas. Regul Pept 83(1):31-38 (Pubitemid 29378363)
29. Oka H, Kameya T, Sato Y, Naritaka H, Kawano N (1999) Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RTPCR and in situ hybridization. J Neurooncol 41(3):197-204 (Pubitemid 29209807)
30. Fujioka N, Morimoto Y, Arai T, Kikuchi M (2004) Discrimination between normal and malignant human gastric tissue by Fourier transform infrared spectroscopy. Cancer Detection Prevent 28:32-36 (Pubitemid 39403831)
31. Fabian H, Jackson M, Murphy L, Watson PH, Fichtner I, Mantsch HH (1995) A comparative infrared spectroscopic study of human breast tumors and breast tumor cell xenografts. Biospectr 1:37-45
32. Eljamel MS (2009) Which intracranial lesions would be suitable for 5-aminolevulenic acid-induced fluorescence-guided identification, localization, or resection? A prospective study of 114 consecutive intracranial lesions. J Neuro Onc 56:93-97